PAVmed Inc. Quarterly Costs and Expenses in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
PAVmed Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2021 to Q3 2024.
  • PAVmed Inc. Costs and Expenses for the quarter ending September 30, 2024 was $12.6M, a 22.9% decline year-over-year.
  • PAVmed Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $59.7M, a 24% decline year-over-year.
  • PAVmed Inc. annual Costs and Expenses for 2023 was $71.2M, a 22.1% decline from 2022.
  • PAVmed Inc. annual Costs and Expenses for 2022 was $91.5M, a 66.6% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $59.7M $12.6M -$3.75M -22.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $63.5M $14.7M -$1.99M -11.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $65.4M $15M -$5.8M -27.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $71.2M $17.4M -$7.28M -29.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 $78.5M $16.3M -$7.12M -30.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $85.7M $16.7M -$6.83M -29.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $92.5M $20.8M +$1.02M +5.16% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $91.5M $24.7M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 $23.4M +$9.58M +69% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $23.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $19.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $13.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.